What’s the latest on sulphonylureas in the management of type 2 diabetes?
Sulphonylureas act by binding to sulphonylurea receptors and stimulating insulin secretion from pancreatic beta cells. This class of oral hypoglycaemic agents is still widely used in the management of type 2 diabetes in patients where lifestyle changes alone are insufficient. Although the older-gene...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
AOSIS
2013-12-01
|
| سلاسل: | South African Family Practice |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://safpj.co.za/index.php/safpj/article/view/3945 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|